Comments
Loading...

Cullinan Therapeutics

CGEMNASDAQ
Logo brought to you by Benzinga Data
$19.60
0.743.92%
At Close: -
$19.60
00.00%
After Hours: Aug 30, 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$40.00
Lowest Price Target1
$19.00
Consensus Price Target1
$29.14

Cullinan Therapeutics (NASDAQ:CGEM) Stock, Analyst Ratings, Price Targets, Forecasts

Cullinan Therapeutics Inc has a consensus price target of $29.14 based on the ratings of 9 analysts. The high is $40 issued by Stifel on May 1, 2024. The low is $19 issued by Morgan Stanley on February 3, 2023. The 3 most-recent analyst ratings were released by Wedbush, HC Wainwright & Co., and HC Wainwright & Co. on August 9, 2024, June 3, 2024, and May 24, 2024, respectively. With an average price target of $30.67 between Wedbush, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 56.46% upside for Cullinan Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
1
Apr
1
May
0
0
0
0
Jun
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Wedbush
HC Wainwright & Co.
Stifel
JonesTrading
BTIG

1calculated from analyst ratings

Analyst Ratings for Cullinan Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Cullinan Therapeutics (CGEM) stock?

A

The latest price target for Cullinan Therapeutics (NASDAQ:CGEM) was reported by Wedbush on August 9, 2024. The analyst firm set a price target for $36.00 expecting CGEM to rise to within 12 months (a possible 83.67% upside). 13 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cullinan Therapeutics (CGEM)?

A

The latest analyst rating for Cullinan Therapeutics (NASDAQ:CGEM) was provided by Wedbush, and Cullinan Therapeutics reiterated their outperform rating.

Q

When was the last upgrade for Cullinan Therapeutics (CGEM)?

A

There is no last upgrade for Cullinan Therapeutics

Q

When was the last downgrade for Cullinan Therapeutics (CGEM)?

A

There is no last downgrade for Cullinan Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Cullinan Therapeutics (CGEM)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cullinan Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cullinan Therapeutics was filed on August 9, 2024 so you should expect the next rating to be made available sometime around August 9, 2025.

Q

Is the Analyst Rating Cullinan Therapeutics (CGEM) correct?

A

While ratings are subjective and will change, the latest Cullinan Therapeutics (CGEM) rating was a reiterated with a price target of $36.00 to $36.00. The current price Cullinan Therapeutics (CGEM) is trading at is $19.60, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch